These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6764011)

  • 21. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing survival in advanced gastric cancer.
    Tabuenca AD; Aitken DR; Ihde JK; Smith J; Garberoglio C
    Am Surg; 1993 Dec; 59(12):855-9. PubMed ID: 8256943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical results of early gastric cancer and proposing a treatment strategy.
    Lo SS; Wu CW; Chen JH; Li AF; Hsieh MC; Shen KH; Lin HJ; Lui WY
    Ann Surg Oncol; 2007 Feb; 14(2):340-7. PubMed ID: 17094028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of the surgical treatment in early gastric cancer.
    Custureri F; D'Orazi V; Peparini N; Gabatel R; Urciuoli P; Patrizi G; Redler A; Di Matteo G
    Hepatogastroenterology; 2004; 51(58):1210-4. PubMed ID: 15239281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-dimer--can it be a marker for malignant gastric lesions?
    Aliustaoglu M; Yumuk PF; Gumus M; Ekenel M; Bolukbas F; Bolukbas C; Mutlu N; Basaran G; Avsar E; Turhal NS
    Acta Oncol; 2004; 43(8):770-1. PubMed ID: 15764225
    [No Abstract]   [Full Text] [Related]  

  • 26. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of the degree of lymphocytic infiltration on the long-term survival of patients undergoing surgery for the exeresis of gastric cancer].
    Di Giorgio A; Botti C; Mingazzini P; Arnone P; Canavese A; Cardini C; Consolo S
    Minerva Chir; 1994; 49(1-2):7-13. PubMed ID: 8208471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long- and short-term survivors after chemotherapy among patients with advanced or recurrent gastric cancer in our hospital].
    Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):599-602. PubMed ID: 18408427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging, stage migration, and patterns of spread in gastric cancer.
    Hundahl SA
    Semin Radiat Oncol; 2002 Apr; 12(2):141-9. PubMed ID: 11979415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopically-assisted palliative total gastrectomy in patients with stage IV or metastatic gastric cancer: is it worthwhile?
    Du J; Li J; Li Y; Ji G; Yang Z; Gao Z; Zheng J
    Hepatogastroenterology; 2008; 55(86-87):1908-12. PubMed ID: 19102420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
    Isozaki H; Tanaka N; Okajima K
    Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complications of combined therapy for stomach cancer].
    Privalov AV; Vazhenin AV
    Vopr Onkol; 2003; 49(1):88-92. PubMed ID: 12715378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laparoscopic surgery of gastric cancer].
    Ibáñez FJ; Azagra JS; Goergen M; Bordas JM; Almendral ML; Erro JM
    An Sist Sanit Navar; 2005; 28 Suppl 3():21-31. PubMed ID: 16511576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and management of gastric adenocarcinoma.
    Waller MB
    Nurs Clin North Am; 2001 Sep; 36(3):543-52, xi. PubMed ID: 11532668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailoring treatments for curable gastric cancer.
    Sano T
    Br J Surg; 2007 Mar; 94(3):263-4. PubMed ID: 17318802
    [No Abstract]   [Full Text] [Related]  

  • 38. Gastric cancer. Diagnosis, treatment and prognosis in clinical routine.
    Borch K; Hammarström LE; Liedberg G
    Acta Chir Scand; 1982; 148(6):517-23. PubMed ID: 7158211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumour-host interaction and prognosis in patients with gastric cancer].
    Păun I; Pop F; Mogoş D; Vasile I; Tenovici M; Păun M; Florescu M; Dumitrelea D; Teodorescu M; Vâlcea D; Gâlcă F
    Chirurgia (Bucur); 2003; 98(3):243-8. PubMed ID: 14997838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric cancer: diagnosis and treatment options.
    Layke JC; Lopez PP
    Am Fam Physician; 2004 Mar; 69(5):1133-40. PubMed ID: 15023013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.